All Pharma News
Go or no go? Esperion`s double whammy and a look to priority reviews

Go or no go? Esperion`s double whammy and a look to priority reviews
EVALUATE
31 Jan 2020
Share Share
Acacia Pharma enters into strategic in-licensing, investment

Acacia Pharma enters into strategic in-licensing, investment
GLOBE NEWSWIRE
10 Jan 2020
Share Share
GHO Capital Acquires Ardena, a Leading CDMO

GHO Capital Acquires Ardena, a Leading CDMO
BUSINESS WIRE
09 Jan 2020
Share Share
Acacia eyes February FDA verdict for refiled nausea drug Barhemsys

Acacia eyes February FDA verdict for refiled nausea drug Barhemsys
Phil Taylor PMLIVE
27 Sep 2019
Share Share
Second CRL given to Acacia after ‘continuing deficiencies’

Second CRL given to Acacia after ‘continuing deficiencies’
Maggie Lynch IN-PHARMATECHNOLOGIST
08 May 2019
Share Share
FDA rejects Acacia’s lead drug — again — due to the same manufacturing issue

FDA rejects Acacia’s lead drug — again — due to the same manufacturing issue
Natalie Grover ENDPTS
04 May 2019
Share Share
Ofloxacin - List of nationally authorised medicinal products

Ofloxacin - List of nationally authorised medicinal products
EMA
11 Dec 2018
Share Share
Acacia’s PONV drug under US review

Acacia’s PONV drug under US review
Selina McKee PHARMA TIMES
08 Jan 2018
Share Share
Former Pfizer, Sanofi and Acacia execs on the move

Former Pfizer, Sanofi and Acacia execs on the move
Flora Southey
22 Nov 2017
Share Share
Acacia Pharma announces +ve result from PIII study of Baremsis to treat PONV

Acacia Pharma announces +ve result from PIII study of Baremsis to treat PONV
PHARMABIZ
15 Aug 2016
Share Share